The Gansu Wuwei Heavy Ion Center has cumulatively treated 2,036 patients in the five years since its
Hua Shang News (Reporter Qi Pengyu) Five years ago, the first domestically developed heavy ion radiotherapy system for tumor treatment was officially put into clinical use. This milestone made China the world’s fourth country to achieve heavy ion tumor treatment, breaking the international monopoly on heavy ion technology and holding significant strategic importance for the development and application of heavy ion technology nationwide.

At the 5th Anniversary Academic Symposium of Wuwei Heavy Ion Center on June 28, reporters learned that the center has treated a total of 2,036 patients to date. It has addressed numerous technical challenges encountered in the clinical application of heavy ion therapy for tumors, accumulated rich clinical experience, and established a comprehensive set of technical specifications and standardized operational procedures. These achievements have laid a solid foundation for the standardization of domestic heavy ion technology systems, making Wuwei Heavy Ion Center a new option for patients with radiation-resistant tumors such as pancreatic cancer and adenoid cystic carcinoma.

Over the past five years, the center has built China’s first heavy ion tumor rehabilitation and health town, realizing full-life cycle health management for tumor patients. By managing and operating the Lanzhou Heavy Ion Center, it has achieved the goal of integrated operation of Gansu Province’s heavy ion treatment systems, positioning Gansu as a national medical center with a distinct focus on heavy ion tumor treatment.

Looking to the future, Gansu Wuwei Cancer Hospital will actively advance the development of cutting-edge new tumor treatment technologies, including light ion therapy, boron neutron capture therapy (BNCT), alpha isotope targeted therapy, and cellular therapy. It will prioritize key tasks such as constructing a heavy ion science and innovation platform, recruiting and cultivating high-level talents, incubating and producing medical equipment, and issuing industry standards for heavy ion technology. The hospital aims to build a national cradle for heavy ion talents, an academic hub, and a research powerhouse, striving to become a national regional medical center for heavy ion radiotherapy with the most comprehensive range of tumor radiotherapy methods in China.
